3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
5
Rhabdoid Tumor
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Sarcoma, Synovial
3
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
3
Wilms Tumor
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Recurrence
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Mesothelioma
2
Medulloblastoma
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Inhibition, Psychological
1
Hodgkin Disease
1
Interventions
pembrolizumab
26
atezolizumab
14
Nivolumab
13
Gemcitabine
13
Cisplatin
10
Docetaxel
8
Carboplatin
8
avelumab
7
Mitomycin
7
epacadostat
4
cabozantinib
4
Ipilimumab
4
pemigatinib
3
Specimen Handling
3
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
vofatamab
2
rucaparib
2
lenvatinib
2
enfortumab vedotin
2
durvalumab
2
cabazitaxel
2
bempegaldesleukin
2
Standard of Care
2
Rogaratinib
2
Ramucirumab
2
Radiation
2
Platinum
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Transitional Cell
×
tazemetostat
×
Clear all
No trials found.